Financhill
Back

United Therapeutics Stock Price Chart

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.

United Therapeutics Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 379.48 Sell
20-day SMA: 375.79 Sell
50-day SMA: 363.31 Buy
200-day SMA: 300.12 Buy
8-day EMA: 373.36 Sell
20-day EMA: 374.93 Sell
50-day EMA: 364.61 Sell
200-day EMA: 314.85 Buy

United Therapeutics Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.54 Buy
Relative Strength Index (14 RSI): 44.48 Sell
Chaikin Money Flow: 110184 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (355.36 - 392.44) Sell
Bollinger Bands (100): (327.49 - 369.99) Buy

United Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for United Therapeutics Stock

Is United Therapeutics Stock a Buy?

UTHR Technical Analysis vs Fundamental Analysis

Sell
50
United Therapeutics (UTHR) is a Sell

Is United Therapeutics a Buy or a Sell?

United Therapeutics Stock Info

Market Cap:
16.27B
Price in USD:
364.33
Share Volume:
192.44K

United Therapeutics 52-Week Range

52-Week High:
417.82
52-Week Low:
208.62
Sell
50
United Therapeutics (UTHR) is a Sell

United Therapeutics Share Price Forecast

Is United Therapeutics Stock a Buy?

  • United Therapeutics share price is 364.33 while UTHR 8-day exponential moving average is 373.36, which is a Sell signal.
  • The stock price of UTHR is 364.33 while United Therapeutics 20-day EMA is 374.93, which makes it a Sell.
  • United Therapeutics 50-day exponential moving average is 364.61 while UTHR share price is 364.33, making it a Sell technically.
  • UTHR stock price is 364.33 and United Therapeutics 200-day simple moving average is 314.85, creating a Buy signal.

Fundamental Analysis of United Therapeutics

Is United Therapeutics a good investment?

  • Analysts estimate an earnings increase this quarter of $1.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $6.10 per share, and an increase next year of $2.37 per share.

Technical Analysis of United Therapeutics

Should I short United Therapeutics stock?

* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.